UAE Molecular Diagnostics Market Size & Outlook, 2025-2030

The molecular diagnostics market in the UAE is expected to reach a projected revenue of US$ 246.0 million by 2030. A compound annual growth rate of 7.4% is expected of the UAE molecular diagnostics market from 2025 to 2030.
Revenue, 2024 (US$M)
$157.2
Forecast, 2030 (US$M)
$246.0
CAGR, 2025 - 2030
7.4%
Report Coverage
UAE

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE molecular diagnostics market, 2018-2030 (US$M)

UAE molecular diagnostics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

UAE molecular diagnostics market highlights

  • The UAE molecular diagnostics market generated a revenue of USD 157.2 million in 2024 and is expected to reach USD 246.0 million by 2030.
  • The UAE market is expected to grow at a CAGR of 7.4% from 2025 to 2030.
  • In terms of segment, reagents was the largest revenue generating product in 2024.
  • Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Molecular diagnostics market data book summary

Market revenue in 2024USD 157.2 million
Market revenue in 2030USD 246.0 million
Growth rate7.4% (CAGR from 2025 to 2030)
Largest segmentReagents
Fastest growing segmentReagents
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Reagents


Other key industry trends

  • In terms of revenue, UAE accounted for 0.6% of the global molecular diagnostics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, UAE molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 246.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Molecular Diagnostics Market Scope

Molecular diagnostics market segmentation & scope

Molecular Diagnostics Market Companies

Name Profile # Employees HQ Website
F. Hoffmann-La Roche Ltd. View profile - - -
Sysmex Corp View profile 10448 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 http://www.sysmex.co.jp
Hologic Inc View profile 6990 250 Campus Drive, Marlborough, MA, United States, 01752 http://www.hologic.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

UAE molecular diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics market will help companies and investors design strategic landscapes.


Reagents was the largest segment with a revenue share of 71.31% in 2024. Horizon Databook has segmented the UAE molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2030.


Being a high-income country, the UAE government aims to provide universal access to updated and advanced healthcare services by 2021. Due to its vast financial resources and adequate government funding, the molecular diagnostics market in UAE is likely to progress steadily.

In May 2024, a groundbreaking laboratory, OncoHelix-CoLab, was launched at a premier quaternary care private hospital in Abu Dhabi, UAE. This state-of-the-art facility specializes in advanced molecular diagnostics, including cancer genomic profiling, transplant diagnostics, and immunology testing.

By utilizing cuttingedge technologies such as next-generation sequencing (NGS), droplet digital PCR, and multi-color flow cytometry, OncoHelix-CoLab provides a range of sophisticated tests that were previously unavailable locally.

Reasons to subscribe to UAE molecular diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UAE molecular diagnostics market databook

  • Our clientele includes a mix of molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UAE molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UAE molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UAE Product - Molecular Diagnostics Market size, 2024 - 2030 (US$M)

UAE Molecular Diagnostics Market Outlook Share, 2024 & 2030 (US$M)

UAE Product - Molecular Diagnostics Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online